Viewing StudyNCT06486883

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-07-17 @ 10:47 AM
Last Modification Date: 2024-10-26 @ 3:34 PM
Study NCT ID: NCT06486883
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-07-05
First Post: 2024-06-17
Brief Title: Safety and Efficacy of T-DXd vs CDK46i-based ET as First-line Therapy of HR-positive and HER2-lowUltralow Advanced Breast Cancer Patients Classified as Non-luminal Subtype
Sponsor: MedSIR
Organization: MedSIR
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Advanced Breast Cancer
Advanced Breast Carcinoma
Hormone Receptor Positive Breast Carcinoma
Keywords: